Skip to content

Advertisement

Medical Gas Research

Research
Open Access

Effects of hydrogen-rich water on abnormalities in a SHR.Cg-Lepr cp /NDmcr rat - a metabolic syndrome rat model

  • Michio Hashimoto1Email author,
  • Masanori Katakura1,
  • Toru Nabika2,
  • Yoko Tanabe1,
  • Shahdat Hossain1, 3,
  • Satoru Tsuchikura4 and
  • Osamu Shido1
Medical Gas Research20111:26

https://doi.org/10.1186/2045-9912-1-26

©  Hashimoto et al; licensee BioMed Central Ltd. 2011

Received: 7 June 2011

Accepted: 3 November 2011

Published: 3 November 2011

Abstract

Background

Hydrogen (H2), a potent free radical scavenger, selectively reduces the hydroxyl radical, which is the most cytotoxic of the reactive oxygen species (ROS). An increase in oxygen free radicals induces oxidative stress, which is known to be involved in the development of metabolic syndrome. Therefore, we investigated whether hydrogen-rich water (HRW) affects metabolic abnormalities in the metabolic syndrome rat model, SHR.Cg-Lepr cp /NDmcr (SHR-cp).

Methods

Male SHR-cp rats (5 weeks old) were divided into 2 groups: an HRW group was given oral HRW for 16 weeks, and a control group was given distilled water. At the end of the experiment, each rat was placed in a metabolic cage for 24 h, fasted for 12 h, and anesthetized; the blood and kidneys were then collected.

Results

Sixteen weeks after HRW administration, the water intake and urine flow measured in the metabolic cages were significantly higher in the HRW group than in the control group. The urinary ratio of albumin to creatinine was significantly lower and creatinine clearance was higher in the HRW group than in the control group. After the 12-h fast, plasma urea nitrogen and creatinine in the HRW group were significantly lower than in the control group. The plasma total antioxidant capacity was significantly higher in the HRW group than in the control group. The glomerulosclerosis score for the HRW group was significantly lower than in the control group, and a significantly positive correlation was observed between this score and plasma urea nitrogen levels.

Conclusion

The present findings suggest that HRW conferred significant benefits against abnormalities in the metabolic syndrome model rats, at least by preventing and ameliorating glomerulosclerosis and creatinine clearance.

Keywords

hydrogen-rich waterrenal glomerulosclerosismetabolic syndrome model ratsoxidative stress

Background

Hydrogen (H2), a potent free radical scavenger, selectively reduces the hydroxyl radical, which is the most cytotoxic of the reactive oxygen species (ROS). In addition, water saturated with H2(H2-rich water) (HRW) orally administered to rats reduces oxidative stress in the animals, suggesting the molecule's anti-oxidative potency. Molecular H2reportedly acts as a therapeutic antioxidant by reducing cytotoxic oxygen radicals [1]; however, its beneficial effects on pathophysiological functions remain unknown.

Oxidative stress represents an imbalance between the production of ROS and the activity of the antioxidant defense system. An increase in oxygen free radicals induces oxidative stress, which is known to be involved in the development of metabolic syndrome. Metabolic syndrome is characterized by a cluster of metabolic risk factors for atherosclerosis, including obesity, insulin resistance, hyperglycemia, hyperlipidemia, and hypertension [2–4]. Metabolic syndrome also increases susceptibility to chronic renal disease [5]. Drinking HRW is a potentially novel therapeutic and preventive strategy against metabolic syndrome [6]. Thus, the antioxidative potency of HRW may affect the development of metabolic syndrome.

Here, with the use of the SHR.Cg-Lepr cp /NDmcr (SHR-cp) rat, a metabolic syndrome rat model, we investigated whether HRW affects the rats' metabolic abnormalities. SHR-cp rats spontaneously develop obesity, hypertension, hyperlipidemia, hyperglycemia, and hyperinsulinemia, i.e., metabolic syndrome [7]. The syndrome is comprised of several risk factors for organ damage that operate at high levels of intensity [8]. Thus, this rat model appears well suited for assessing the renal changes induced by broad metabolic abnormalities and the development of glomerular damage such as focal and segmental glomerulosclerosis.

Materials and methods

Animals

Male SHR-cp rats (5 weeks old) supplied by the Disease Model Cooperative Research Association (Kyoto, Japan) were randomly divided into 2 groups: an HRW group (n = 12) was given oral HRW for 16 weeks, and a control group (n = 12) was given distilled water. Nakao et al. have described the production and characterization of HRW [6]. HRW was prepared by dipping a plastic-shelled product (stick) consisting of metallic magnesium (99.9% pure) and natural stones (Doctor SUISOSUI®; Friendear Inc., Tokyo, Japan) into distilled water. HRW was freshly prepared every other day in a 200-mL bottle containing the stick, and the H2concentration was maintained between 0.3 and 0.4 ppm during the experiment. The HRW contained 23 mg/L of calcium, 5 mg/L of magnesium, 19 mg/L of sodium, less than 1 mg/L of potassium and a pH of 7.2. SHR-cp rats were housed in an air-conditioned animal room with a 12:12-h dark:light cycle under controlled temperature (23 ± 2°C) and humidity (50 ± 10% relative humidity). They were given free access to a Quick Fat diet (CLEA Japan Inc., Tokyo, Japan) and a bottle containing either HRW or distilled water. The water intake of the rats was measured every 2 days. All animal experiments were carried out in accordance with the procedures outlined in the Guidelines for Animal Experimentation of Shimane University compiled from the Guidelines for Animal Experimentation of the Japanese Association for Laboratory Animal Science.

Urine and blood collection

After 16 weeks of HRW ingestion, each rat was weighed and placed in a metabolic cage for 24-h urine collection. Following this, the rat was fasted for 12 h and anesthetized with intraperitoneal sodium pentobarbital (65 mg/kg); its blood was then collected and its kidneys excised.

Biochemical measurements in blood and urine

Plasma total cholesterol, triglycerides, glucose, creatinine and blood urea nitrogen (BUN) concentrations were determined with an automatic analyzer (BiOLiS 24i; Tokyo Boeki Medical System Ltd., Tokyo, Japan). The concentration of 8-hydroxy-2'-deoxyguanosine (8-OHdG) in plasma was determined by enzyme immunoassay (Highly Sensitive 8-OHdG Check; Japan Institute for the Control of Aging, Shizuoka, Japan). The plasma total antioxidant capacity levels were determined by the biological antioxidant potential (BAP) test (Free Radical Analytical System 4; H&D srl, Parma, Italy). The BAP measurement is based on the ability of a colored solution containing a source of ferric (Fe3+) ions adequately bound to a special chromogenic substrate (thiocyanate derivative) to discolor when Fe3+ions are reduced to ferrous ions (Fe2+) in response to the reducing activity of blood samples [9]. Urine albumin and creatinine levels were measured using the Nephrat kit for the quantitation of rat urinary albumin and the Creatinine Companion kit (Exocell, Philadelphia, PA) according to the manufacture's instructions. The ratio of the concentrations of albumin to creatinine (AC ratio) in urine was used as an index of urinary albumin excretion. Endogenous creatinine clearance (CrCl) was determined as CrCl = Ucr × V × Pcr-1, where Ucr and Pcr are urinary and plasma creatinine concentrations, respectively, and V is urine flow. The Ucr and V values were calculated from the data of SHR-cp rats in metabolic cages, and Pcr values were cited from Table 1. The CrCl was used as an index of glomerular filtration rate (GFR).
Table 1

Biochemical parameters of plasma

 

Control group (n = 12)

HRW group (n = 12)

Triglyceride (mg/dL)

443.9 ± 34.5

548.8 ± 50.4

Total cholesterol (mg/dL)

151.3 ± 4.8

153.3 ± 7.6

Glucose (mg/dL)

217.0 ± 35.8

229.2 ± 45.6

BUN (mg/dL)

24.0 ± 0.7

20.9 ± 0.7*

Creatinine (mg/dL)

0.25 ± 0.02

0.20 ± 0.01*

BAP (μmol/L)

2148 ± 91.6

2620 ± 159*

8-OHdG (μg/mL)

0.266 ± 0.02

0.250 ± 0.01

BAP, biological antioxidant potential; BUN, blood urea nitrogen; HRW group; rats orally administered with hydrogen-rich water; 8-OHdG, 8-hydroxy-deoxyguanosine.

At the end of this study, each rat was weighed and placed in a metabolic cage for 24-h urine collection. After urine collection, the rat was fasted for 12 h and anesthetized, and its blood was collected. Values represent mean ± SE. *P < 0.05.

Morphological analysis

Coronal sections of renal tissue (3-4 μm thick) were stained with periodic acid-Schiff (PAS) and examined by light microscopy in a blinded fashion. Glomerulosclerosis was semi-quantitatively evaluated according to criteria developed by Uehara et al[10]. Briefly, 50 glomeruli were randomly selected from each animal for morphometric analysis. Glomerulosclerosis, defined as synechiae formation by PAS staining with focal or global obliteration of capillary loops, was graded as follows: 1+, < 30% of glomerular area affected; 2+, 30% to 70% affected and 3+, > 70% affected. The overall glomerulosclerosis score per animal was the average grade of all the glomeruli evaluated.

Statistical analysis

All data are expressed as the means ± SE. Significant differences between HRW and control groups were determined by the unpaired Student's t-test. Correlation was determined by Pearson's correlation analysis. Differences of P < 0.05 were considered significant. PASW Statistics 18 was used for the statistical analysis (SPSS Inc., Chicago, IL, USA).

Results

Body weight and HRW intake

HRW administration did not affect the body weight of SHR-cp rats throughout the experimental period (Figure 1). The volume of water intake per 24 h measured in the metabolic cages was larger in the HRW group than in the control group (Table 2).
Figure 1
Figure 1

Effect of HRW administration on body weight. White circle, distilled water-administered rats (control, n = 12); black circle, hydrogen-rich water-administered rats (HRW, n = 12). *P < 0.05.

Table 2

Effects of hydrogen-rich water (HRW) on water intake and renal functions in SHR-cp rats

 

Water intake

Urine flow

Urine

  

Creatinine clearance

   

Albumin (A)

Creatinine (C)

AC ratio

 
 

(mL/kg BW. day)

(mL/kg BW. day)

(mg/kg BW. day)

(mg/kg BW. day)

 

(mL/min)

Control group

71.1 ± 1.8

47.5 ± 2.4

161.7 ± 14.0

24.4 ± 1.3

6.81 ± 0.64

5.16 ± 0.4

(n = 10)

      

HRW group

113.7 ± 3.5*

62.0 ± 6.3*

129.9 ± 10.9

25.1 ± 0.6

5.17 ± 0.42*

6.28 ± 0.36*

(n = 11)

      

Values are mean ± SE. *P < 0.05, BW, body weight; AC ratio, albumin to creatinine ratio.

These data were obtained from SHR-cp rats housed for 24 h in metabolic cages, except that of plasma creatinine concentrations, which were cited in Table 1.

Plasma biochemical data, water intake, and parameters of renal functions

The plasma biochemical data in the control and HRW rats fasted for 12 h after 16 weeks are listed in Table 1. Plasma BUN and creatinine concentrations were significantly lower in the HRW group than in the control group. There was no significant difference in the concentrations of plasma triglyceride, total cholesterol, or the level of plasma 8-OHdG between the 2 groups; however, the plasma BAP level in the HRW group was significantly higher.

The water intake and renal function parameters measured in the metabolic cages at 16 weeks of HRW administration are listed in Table 2. Water intake and urine flow measured for 24 h in the metabolic cages were significantly higher in the HRW group than in the control group. Urine albumin was lower, but not significantly so, in the HRW group than in the controls (0.05 < P < 0.1), leading to an albumin to creatinine ratio of 24.1% in the HRW group that was significantly lower than that in the control group. CrCl increased with HRW administration in SHR-cp rats, with a 21.7% potentiation compared with the control group.

Effect of HRW administration on glomerular sclerosis

HRW administration inhibited histological damage to the kidneys of SHR-cp rats (Figure 2). The glomerular sclerosis score was significantly lower in the HRW group (1.46 ± 0.06) than in the control group (1.75 ± 0.11) (Figure 3A). Simple regression analyses were performed to determine whether an alteration in the glomerulosclerosis score was associated with plasma BUN and other parameters used as indices of kidney damage. A significantly positive correlation was observed only between the glomerulosclerosis score and plasma BUN levels (Figure 3B), while correlation of the former with other variables such as water intake, urine flow, and CrCl was not statistically significant.
Figure 2
Figure 2

Photomicrographs of coronal sections of the glomeruli from SHR-cp rats. (A) Control group. (B) HRW group. Periodic acid-Schiff (PAS) staining of the control group revealed glomerular damage, which was characterized by segmental glomerular sclerosis and the formation of synechiae by the attachment of parietal epithelial cells to the denuded glomerular basement membrane (PAS stain, original magnification ×400).

Figure 3
Figure 3

Effect of HRW administration on glomerular sclerosis. After 16 weeks of HRW administration, coronal sections of the renal tissue from distilled water-administered rats (control, n = 8) and HRW-administered rats (HRW, n = 7) were stained with PAS and examined by light microscopy in a blinded fashion (Figure 3A). Glomerulosclerosis was semi-quantitatively evaluated according to the criteria developed by Uehara et al. [10]. *P < 0.05. Data represent mean ± SE. Figure 3B illustrates the relationship between the glomerulosclerosis score and concentrations of blood urea nitrogen. White and black circles indicate control and HRW rats, respectively.

Discussion

The hydroxyl radical and peroxynitrite are the strongest oxidants that react indiscriminately with nucleic acids, lipids, and proteins, resulting in DNA fragmentation, lipid peroxidation, and protein inactivation. Molecular H2reduces the hydroxyl radical and peroxynitrite in vitroand induces therapeutic antioxidant activity in the rat middle cerebral artery occlusion model [1]. HRW ingestion reduces oxidative stress in human subjects with potential metabolic syndrome, suggesting that HRW represents a potentially novel therapeutic and preventive strategy for metabolic syndrome [6]. Oxidative stress represents an imbalance between the production of ROS and the activity of the antioxidant defense system. Cardinal et al. reported that both local and systemic concentrations of H2measured in the kidneys and serum following oral administration of HRW peaked within 15 min after ingestion, proving that HRW is an effective mode of delivery for H2[11]. The continuous incorporation of H2from the stomach into the blood may alter the state of blood components to a reductive one. Indeed, the plasma BAP levels of SHR-cp rats in the HRW group were significantly higher than that in the control group (Table 1) in this study. Therefore, continuous exposure to H2may influence the oxidative state in organ tissues.

Light microscopy has shown that SHR-cp rats develop glomerular damage, mesangial expansion, and focal and segmental glomerular sclerosis; thus, the glomerulosclerosis score in SHR-cp rats is higher than that in Wistar Kyoto (WKY) rats [8]. In the present study, the glomerulosclerosis score in the HRW group was lower than that in the control group (Figure 3A), suggesting a preventive effect of HRW administration on the development of histologically evident glomerular injury observed in the SHR-cp rats. Increases in plasma creatinine and/or BUN levels were considered indices of damage to renal function. Indeed, the BUN level in SHR-cp rats is 1.65 times greater than that in WKY rats [8]. In this study, HRW administration decreased the plasma BUN and creatinine levels of the SHR-cp rats compared with those of the control rats (Table 1). The HRW administration-induced decreases in plasma BUN and creatinine levels were consistent with the results recently reported by Nakashima-Kaminura et al[12]. They reported that HRW prevented metamorphosis-associated decreased apoptosis in the kidney and nephrotoxicity as assessed by serum creatinine and BUN levels. Moreover, HRW ingestion significantly decreases plasma creatinine levels in human subjects with potential metabolic syndrome [6]. These results suggest that continuous HRW administration appears to prevent and ameliorate histological damage to the kidneys.

Recent studies have indicated that metabolic syndrome increases susceptibility to chronic kidney disease [5]. Glomerular and tubulointerstitial damage characteristic of human type II diabetic nephropathy (e.g., focal and segmental glomerular sclerosis) develops in SHR-cp rats together with evidence of increased oxidative stress [13]. In this study, continuous administration of HRW did not affect the body weight or plasma levels of triglycerides, total cholesterol, or glucose in SHR-cp rats, but significantly inhibited the deterioration of glomerulosclerosis. Continuous HRW administration also decreased the urinary AC ratio, which can be used to diagnose the early stages of diabetic nephropathy in patients with diabetes [14]. In clinical practice, the measurement of CrCl remains the most widely used method for obtaining a GFR index. SHR-cp rats develop progressive diabetic nephropathy with severe proteinurial and histological abnormalities, which are associated with a decrease in CrCl as compared with WKY rats [15]. In this experiment, HRW administration significantly increased the levels of CrCl in SHR-cp rats (Table 2). These results suggest that the intake of HRW inhibited renal dysfunction in metabolic syndrome model rats. The mechanisms of the increased water intake and urine flow in HRW-administered SHR-cp rats remain to be elucidated. From the present data, it is difficult to clarify the possible causes and consequences of these increments. Typically, urine flow, urinary flow of creatinine, and/or CrCl as GFR indices are multifactorial phenomena. The increase in GFR and the decrease in the AC ratio observed in HRW-administered SHR-cp rats suggest that continuous HRW administration inhibits the development of renal dysfunction, leading to the increased urine flow and, presumably, the increased water intake. Further experiments are required to confirm this.

From the data obtained in this study, it is difficult to clarify the mechanisms underlying the beneficial effects of HRW on renal diseases. The HRW administration-induced increase in water intake, urine flow, and CrCl, and/or the decrease in oxidative stress observed in this study may play a role in this ameliorating effect in SHR-cp rats. Cardinal et al. recently reported that oral HRW administration prevents chronic allograft nephropathy after renal transplantation via the ability of molecular H2to reduce oxidative stress-induced damage [11]. Antioxidant enzymes do not detoxify the hydroxyl radical and peroxynitrite, which are target oxidants of molecular H2, because no enzyme detoxifies these radicals. H2therapy reduces apoptosis by suppressing caspase activity in the neonatal hypoxia-ischemia rat model [16]. It is also reported that a sufficient supply of H2-rich pure water may prevent or delay the development and progression of type II diabetes mellitus by providing protection against oxidative stress [17]. Therefore, our studies suggest that HRW may have direct effects on kidney function and that its administration appeared to ameliorate glomerular damage in a rat model of metabolic syndrome, possibly by limiting oxidative stress. Further studies are needed to confirm these mechanisms.

Conclusions

The present study was designed to evaluate whether HRW ingestion would have an ameliorative effect on a host of metabolic abnormalities, including glomerulosclerotic damage, blood creatinine and BUN levels, oxidative potentials, urinary flow, and GFR in metabolic syndrome model rats. Based on the biochemical and renal parameter results and morphological changes in the kidneys, the present study clearly indicates that HRW conferred significant benefits against these abnormalities in metabolic syndrome model rats.

List of abbreviations

The abbreviations used are: 

AC ratio: ratio of the concentrations of albumin to creatinine

BAP: 

biological antioxidant potential

BUN: 

blood urea nitrogen

CrCl: 

creatinine clearance

GFR: 

glomerular filtration rate

HRW: 

hydrogen-rich water

8-OHdG: 

8-hydroxy-2'-deoxyguanosine

PAS: 

periodic acid-Schiff

ROS: 

reactive oxygen species

SHR-cp: 

SHR.Cg-Lepr cp /NDmcr

WKY: 

Wistar Kyoto.

Declarations

Acknowledgements

The authors thank Professor Hideki Okunishi and technician Keiko Shimoura of the Department of Pharmacology at Shimane University Faculty of Medicine, for preparing coronal sections of renal tissues. We also thank Friendear Inc. (Tokyo, Japan) for its generous gift of metallic magnesium sticks (Doctor SUISOSUI®, Friendear Inc.). This study was supported in part by a grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (19500324 to MH).

Authors’ Affiliations

(1)
Department of Environmental Physiology, Shimane University Faculty of Medicine, Izumo, Shimane, Japan
(2)
Department of Functional Pathology, Shimane University Faculty of Medicine, Izumo, Shimane, Japan
(3)
Department of Biochemistry and Molecular Biology, Jahangirnagar University, Savar, Bangladesh
(4)
Disease Model Cooperative Research Association, Hamamatsu, Japan

References

  1. Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S, Ohta S: Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007, 13: 688-694. 10.1038/nm1577.View ArticlePubMedGoogle Scholar
  2. Dzau VJ: Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension. 2001, 37: 1047-1052.View ArticlePubMedGoogle Scholar
  3. Taniyama Y, Griendling KK: Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension. 2003, 42: 1075-1081. 10.1161/01.HYP.0000100443.09293.4F.View ArticlePubMedGoogle Scholar
  4. Ihara Y, Toyokuni S, Uchida K, Odaka H, Tanaka T, Ikeda H, Hiai H, Seino Y, Yamada Y: Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes. 1999, 48: 927-932. 10.2337/diabetes.48.4.927.View ArticlePubMedGoogle Scholar
  5. Kurella M, Lo JC, Chertow GM: Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005, 16: 2134-2140. 10.1681/ASN.2005010106.View ArticlePubMedGoogle Scholar
  6. Nakao A, Toyoda Y, Sharma P, Evans M, Guthrie N: Effectiveness of hydrogen rich water on antioxidant status of subjects with potential metabolic syndrome-an open label pilot study. J Clin Biochem Nutr. 2010, 46: 140-149. 10.3164/jcbn.09-100.PubMed CentralView ArticlePubMedGoogle Scholar
  7. Michaelis OEt, Ellwood KC, Judge JM, Schoene NW, Hansen CT: Effect of dietary sucrose on the SHR/N-corpulent rat: a new model for insulin-independent diabetes. Am J Clin Nutr. 1984, 39: 612-618.PubMedGoogle Scholar
  8. Nangaku M, Izuhara Y, Usuda N, Inagi R, Shibata T, Sugiyama S, Kurokawa K, van Ypersele de Strihou C, Miyata T: In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy. Nephrol Dial Transplant. 2005, 20: 2661-2669. 10.1093/ndt/gfi096.View ArticlePubMedGoogle Scholar
  9. Dohi K, Satoh K, Ohtaki H, Shioda S, Miyake Y, Shindo M, Aruga T: Elevated plasma levels of bilirubin in patients with neurotrauma reflect its pathophysiological role in free radical scavenging. In Vivo. 2005, 19: 855-860.PubMedGoogle Scholar
  10. Uehara Y, Hirawa N, Kawabata Y, Suzuki T, Ohshima N, Oka K, Ikeda T, Goto A, Toyo-oka T, Kizuki K: Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats. Hypertension. 1994, 24: 770-778.View ArticlePubMedGoogle Scholar
  11. Cardinal JS, Zhan J, Wang Y, Sugimoto R, Tsung A, McCurry KR, Billiar TR, Nakao A: Oral hydrogen water prevents chronic allograft nephropathy in rats. Kidney Int. 2010, 77: 101-109. 10.1038/ki.2009.421.View ArticlePubMedGoogle Scholar
  12. Nakashima-Kamimura N, Mori T, Ohsawa I, Asoh S, Ohta S: Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice. Cancer Chemother Pharmacol. 2009, 64: 753-761. 10.1007/s00280-008-0924-2.View ArticlePubMedGoogle Scholar
  13. Izuhara Y, Nangaku M, Inagi R, Tominaga N, Aizawa T, Kurokawa K, van Ypersele de Strihou C, Miyata T: Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering. J Am Soc Nephrol. 2005, 16: 3631-3641. 10.1681/ASN.2005050522.View ArticlePubMedGoogle Scholar
  14. Mogensen CE: Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int. 1987, 31: 673-689. 10.1038/ki.1987.50.View ArticlePubMedGoogle Scholar
  15. Ohtomo S, Izuhara Y, Takizawa S, Yamada N, Kakuta T, van Ypersele de Strihou C, Miyata T: Thiazolidinediones provide better renoprotection than insulin in an obese, hypertensive type II diabetic rat model. Kidney Int. 2007, 72: 1512-1519. 10.1038/sj.ki.5002570.View ArticlePubMedGoogle Scholar
  16. Cai J, Kang Z, Liu WW, Luo X, Qiang S, Zhang JH, Ohta S, Sun X, Xu W, Tao H, Li R: Hydrogen therapy reduces apoptosis in neonatal hypoxia-ischemia rat model. Neurosci Lett. 2008, 441: 167-172. 10.1016/j.neulet.2008.05.077.View ArticlePubMedGoogle Scholar
  17. Kajiyama S, Hasegawa G, Asano M, Hosoda H, Fukui M, Nakamura N, Kitawaki J, Imai S, Nakano K, Ohta M, Adachi T, Obayashi H, Yoshikawa T: Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutr Res. 2008, 28: 137-143. 10.1016/j.nutres.2008.01.008.View ArticlePubMedGoogle Scholar

Copyright

© Hashimoto et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement

Medical Gas Research

ISSN: 2045-9912

Contact us